205 related articles for article (PubMed ID: 23717689)
1. P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation.
Gillette M; Bray K; Blumenthaler A; Vargo-Gogola T
PLoS One; 2013; 8(5):e65105. PubMed ID: 23717689
[TBL] [Abstract][Full Text] [Related]
2. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
3. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
Heckman-Stoddard BM; Vargo-Gogola T; McHenry PR; Jiang V; Herrick MP; Hilsenbeck SG; Settleman J; Rosen JM
Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301
[TBL] [Abstract][Full Text] [Related]
6. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
7. SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling.
Koledova Z; Zhang X; Streuli C; Clarke RB; Klein OD; Werb Z; Lu P
Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5731-40. PubMed ID: 27621461
[TBL] [Abstract][Full Text] [Related]
8. P190A RhoGAP is required for mammary gland development.
Heckman-Stoddard BM; Vargo-Gogola T; Herrick MP; Visbal AP; Lewis MT; Settleman J; Rosen JM
Dev Biol; 2011 Dec; 360(1):1-10. PubMed ID: 21945077
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
10. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
11. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
Lazarus KA; Brown KA; Young MJ; Zhao Z; Coulson RS; Chand AL; Clyne CD
Endocrinology; 2014 May; 155(5):1606-17. PubMed ID: 24564400
[TBL] [Abstract][Full Text] [Related]
12. FGF signaling in mammary gland fibroblasts regulates multiple fibroblast functions and mammary epithelial morphogenesis.
Sumbal J; Koledova Z
Development; 2019 Dec; 146(23):. PubMed ID: 31699800
[TBL] [Abstract][Full Text] [Related]
13. A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans.
Ibrahim AM; Bilsland A; Rickelt S; Morris JS; Stein T
Breast Cancer Res; 2021 Sep; 23(1):90. PubMed ID: 34565423
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.
König A; Bruckner-Tuderman L
Lab Invest; 1994 Feb; 70(2):203-9. PubMed ID: 8139261
[TBL] [Abstract][Full Text] [Related]
15. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR; Johnson KM; Nemenoff RA; Schiemann WP
Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385
[TBL] [Abstract][Full Text] [Related]
16. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
17. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes.
Hattar R; Maller O; McDaniel S; Hansen KC; Hedman KJ; Lyons TR; Lucia S; Wilson RS; Schedin P
Breast Cancer Res; 2009; 11(1):R5. PubMed ID: 19173736
[TBL] [Abstract][Full Text] [Related]
19. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK; Smith JA; Schiemann WP
J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
[TBL] [Abstract][Full Text] [Related]
20. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
